← Eichor
Study identifier: NCT06563466 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

PEGASUS - Improving Treatment for Patients With Emotionally Unstable Personality Disorder

Condition: Borderline Personality Disorder · Relatives  ·  Sponsor: University Hospital Bispebjerg and Frederiksberg

PhaseNA
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The purpose of the PEGASUS study is to conduct a pilot trial to test the feasibility and acceptability of the PEGASUS intervention, adding a case manager and family-based interventions meetings to the existing psychiatric integrated care-models known as "Treatment Packages" in Denmark. We will conduct a randomized, assessor-blinded parallel-groups superiority clinical trial, testing the PEGASUS intervention for emotionally unstable personality disorder "EUPD", borderline type (borderline personality disorder) compared to "Treatment as Usual" before moving on to testing in a full-scale trial. Participants will be assessed at baseline and 9 month post baseline at study conclusion

This description comes directly from the study's public registry record.

Talk to the study team

Ditte H. Rotvig, MD  ·  +45 31154887  ·  ditte.hoeyer.rotvig@regionh.dk

Carsten Hjorthøj, Ph.d.  ·  +45 26136290  ·  carsten.hjorthoej@regionh.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Copenhagen Research Center for Mental Health - CORECopenhagen, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06563466